Skip to main content

Table 14 Difference in means between treatment and control groups for BMI at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author

Sample size (treatment group vs. control group)

Difference

95% CI

Caraccio et al. [58]

49 (24 vs. 25)

1.30 kg/m2*

− 0.33 to 2.93

Caraccio et al. [59]

23 (12 vs. 11)

− 0.40 kg/m2*

− 2.52 to 1.72

Duman et al. [60]

39 (20 vs. 19)

− 0.70 kg/m2*

− 2.91 to 1.51

Iqbal et al. [62]

64 (32 vs. 32)

1.40 kg/m2*

− 1.06 to 3.86

Liu et al. [64]

119 (60 vs. 59)

− 0.10 kg/m2**

− 0.51 to 0.31

Monzani et al. [67]

20 (10 vs. 10)

0.00 kg/m2*

− 3.22 to 3.22

Monzani et al. [68]

45 (23 vs. 22)

− 1.20 kg/m2*

− 3.34 to 0.94

Nagasaki et al. [69]

95 (48 vs. 47)

− 0.30 kg/m2**

− 1.26 to 0.66

Stott et al. [73]

638 (318 vs. 320)

0.0 kg/m2*

− 0.02 to 0.02

Teixeira et al. [74, 75]

26 (11 vs. 15)

2.90 kg/m2*

0.38–5.42

Yazici et al. [76]

45 (23 vs. 22)

− 0.20 kg/m2*

− 2.10 to 1.70

  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group